Epizyme Announces Date of First Quarter 2022 Financial Results

Rhea-AI Summary

Epizyme (NASDAQ: EPZM) is set to host a conference call on May 10, 2022, at 8:30 a.m. ET, to discuss its first quarter financial results and provide a business update. Investors can participate by calling (877) 844-6886 for domestic or (970) 315-0315 for international inquiries, using conference ID 5369344. A live webcast will also be available on the company's website and archived for 60 days afterward. Epizyme focuses on developing innovative cancer therapies that leverage novel epigenetic targets.

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Epizyme, (Nasdaq: EPZM), a fully integrated, commercial-stage biopharmaceutical company developing and delivering transformative therapies for cancer patients against novel epigenetic targets, today announced that management will host a conference call to discuss its first quarter 2022 financial results and provide a business update on Tuesday, May 10, 2022 at 8:30 a.m. ET.

To participate in the conference call, please dial (877) 844-6886 (domestic) or (970) 315-0315 (international) and refer to conference ID 5369344. A live webcast will be available in the investor section of the company's website at www.epizyme.com, and will be archived for 60 days following the call.

About Epizyme, Inc.

Epizyme, Inc. is a fully integrated, commercial-stage biopharmaceutical company committed to its mission of rewriting treatment for cancer through novel epigenetic medicines. The Company is focused on creating medicines that are targeted at specific causes of diseases, that are orally administered, tolerable, easy to take and based on a deep understanding of the patients that may benefit from them. The Company aspires to change the standard-of-care for patients and physicians by developing medicines with fundamentally new mechanisms of action. For more information, visit www.epizyme.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220503005288/en/

Media:

Erin Graves

media@epizyme.com

(617) 500-0615

Investors:

Caitlin Stern

Real Chemistry

cstern@realchemistry.com

Source: Epizyme, Inc.

FAQ

When will Epizyme announce its Q1 financial results?

Epizyme will announce its Q1 financial results on May 10, 2022.

What time is the Epizyme conference call scheduled?

The Epizyme conference call is scheduled for 8:30 a.m. ET.

How can I participate in the Epizyme conference call?

To participate, call (877) 844-6886 for domestic or (970) 315-0315 for international and use conference ID 5369344.

Will there be a webcast for the Epizyme Q1 results call?

Yes, a live webcast will be available on Epizyme’s investor website.

How long will the Epizyme conference call be archived?

The conference call will be archived for 60 days following the event.